SAN DIEGO, Oct. 24 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. announced today that the Company will report third quarter 2005 financial results after the Nasdaq market closes Monday, October 24, 2005. Neurocrine will then host a live conference call and Webcast to discuss its third quarter financial results and provide a Company update Monday afternoon, October 24, 2005 at 4:30 PM Eastern Daylight Time (EDT) / 1:30 PM Pacific Daylight Time (PDT). Participants may access the live Conference Call by dialing 1-800-540-0559 (U.S.) or 785-832-0326 (International) and using the Conference ID# NBIX. The call can also be accessed via the Webcast through the Company’s website at http://www.neurocrine.com
If you are unable to attend the Webcast and would like further information on this announcement, please contact Claudia Woodworth or Elizabeth Foster in the Investor Relations Department at Neurocrine Biosciences at (858) 617-7600. A replay of the Conference Call will be available approximately one hour after the conclusion of the call by dialing 1-800-839-3607 (US) or 402-220-2970 (International) and will be archived until Monday, November 7, 2005.
Neurocrine Biosciences, Inc. is a product-based biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world including insomnia, anxiety, depression, diabetes, multiple sclerosis, irritable bowel syndrome, eating disorders, pain, and autoimmunity. Neurocrine Biosciences, Inc. news releases are available through the Company’s website via the Internet at http://www.neurocrine.com
Neurocrine Biosciences, Inc.
CONTACT: Claudia Woodworth or Elizabeth Foster, +1-858-617-7600, both ofNeurocrine Biosciences, Inc.
Web site: http://www.neurocrine.com/
